These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36642283)

  • 1. In situ gelling drug delivery systems for topical drug delivery.
    Kolawole OM; Cook MT
    Eur J Pharm Biopharm; 2023 Mar; 184():36-49. PubMed ID: 36642283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel in situ gelling ophthalmic drug delivery system based on gellan gum and hydroxyethylcellulose: Innovative rheological characterization, in vitro and in vivo evidence of a sustained precorneal retention time.
    Destruel PL; Zeng N; Seguin J; Douat S; Rosa F; Brignole-Baudouin F; Dufaÿ S; Dufaÿ-Wojcicki A; Maury M; Mignet N; Boudy V
    Int J Pharm; 2020 Jan; 574():118734. PubMed ID: 31705970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing ophthalmic delivery of a poorly water soluble drug from an aqueous in situ gelling system.
    Senjoti FG; Timmins P; Conway BR; Smith AM
    Eur J Pharm Biopharm; 2020 Sep; 154():1-7. PubMed ID: 32599271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Situ Forming Depot as Sustained-Release Drug Delivery Systems.
    Kanwar N; Sinha VR
    Crit Rev Ther Drug Carrier Syst; 2019; 36(2):93-136. PubMed ID: 30806210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation strategies to modulate drug release from poloxamer based in situ gelling systems.
    Abdeltawab H; Svirskis D; Sharma M
    Expert Opin Drug Deliv; 2020 Apr; 17(4):495-509. PubMed ID: 32067500
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent Advances in the Development of In Situ Gelling Drug Delivery Systems for Non-Parenteral Administration Routes.
    Vigani B; Rossi S; Sandri G; Bonferoni MC; Caramella CM; Ferrari F
    Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan/β-glycerophosphate
    Kolawole OM; Lau WM; Khutoryanskiy VV
    Int J Pharm X; 2019 Dec; 1():100007. PubMed ID: 31517272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In situ gelling and mucoadhesive polymers: why do they need each other?
    Zahir-Jouzdani F; Wolf JD; Atyabi F; Bernkop-Schnürch A
    Expert Opin Drug Deliv; 2018 Oct; 15(10):1007-1019. PubMed ID: 30173567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levofloxacin Hemihydrate In Situ Gelling Ophthalmic Solution: Formulation Optimization and In Vitro and In Vivo Evaluation.
    Bhalerao H; Koteshwara KB; Chandran S
    AAPS PharmSciTech; 2019 Aug; 20(7):272. PubMed ID: 31372767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucoadhesive In Situ Gelling Liquid Crystalline Precursor System to Improve the Vaginal Administration of Drugs.
    de Araújo PR; Calixto GMF; da Silva IC; de Paula Zago LH; Oshiro Junior JA; Pavan FR; Ribeiro AO; Fontana CR; Chorilli M
    AAPS PharmSciTech; 2019 Jun; 20(6):225. PubMed ID: 31214798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine.
    Chen Y; Liu Y; Xie J; Zheng Q; Yue P; Chen L; Hu P; Yang M
    Int J Nanomedicine; 2020; 15():10435-10451. PubMed ID: 33380794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In situ gelling systems for ocular drug delivery.
    Ahmed B; Jaiswal S; Naryal S; Shah RM; Alany RG; Kaur IP
    J Control Release; 2024 Jul; 371():67-84. PubMed ID: 38768662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiolated poly(aspartic acid) as potential in situ gelling, ocular mucoadhesive drug delivery system.
    Horvát G; Gyarmati B; Berkó S; Szabó-Révész P; Szilágyi BÁ; Szilágyi A; Soós J; Sandri G; Bonferoni MC; Rossi S; Ferrari F; Caramella C; Csányi E; Budai-Szűcs M
    Eur J Pharm Sci; 2015 Jan; 67():1-11. PubMed ID: 25445832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral liquid in situ gelling methylcellulose/alginate formulations for sustained drug delivery to dysphagic patients.
    Shimoyama T; Itoh K; Kobayashi M; Miyazaki S; D'Emanuele A; Attwood D
    Drug Dev Ind Pharm; 2012 Aug; 38(8):952-60. PubMed ID: 22283456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hp-β-CD-voriconazole in situ gelling system for ocular drug delivery: in vitro, stability, and antifungal activities assessment.
    Pawar P; Kashyap H; Malhotra S; Sindhu R
    Biomed Res Int; 2013; 2013():341218. PubMed ID: 23762839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Monoglyceride Content Affects the Self-Assembly Behavior, Rheological Properties, Syringeability, and Mucoadhesion of In Situ-Gelling Liquid Crystalline Phase.
    Nunes KM; Teixeira CC; Kaminski RC; Sarmento VH; Couto RO; Pulcinelli SH; Freitas O
    J Pharm Sci; 2016 Aug; 105(8):2355-64. PubMed ID: 27339408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route.
    Chowhan A; Giri TK
    Int J Biol Macromol; 2020 May; 150():559-572. PubMed ID: 32057864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancement in stimuli triggered in situ gelling delivery for local and systemic route.
    Ajazuddin ; Alexander A; Khan J; Giri TK; Tripathi DK; Saraf S; Saraf S
    Expert Opin Drug Deliv; 2012 Dec; 9(12):1573-92. PubMed ID: 23075325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rheo-dissolution: A new platform for the simultaneous measurement of rheology and drug release.
    Senjoti FG; Ghori MU; Diryak R; Conway BR; Morris GA; Smith AM
    Carbohydr Polym; 2020 Feb; 229():115541. PubMed ID: 31826516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholesterol in situ forming gel loaded with doxycycline hyclate for intra-periodontal pocket delivery.
    Phaechamud T; Setthajindalert O
    Eur J Pharm Sci; 2017 Mar; 99():258-265. PubMed ID: 28027940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.